Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALMOTRIPTAN MALATE vs ALOGLIPTIN\METFORMIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALMOTRIPTAN MALATE vs ALOGLIPTIN\METFORMIN: Safety Overview

Metric ALMOTRIPTAN MALATE ALOGLIPTIN\METFORMIN
Total FAERS Reports 497 372
Deaths Reported 3 27
Death Rate 0.6% 7.3%
Hospitalizations 60 143
Average Patient Age 52.4 yrs 67.2 yrs
% Female Patients 16.5% 42.0%
FDA Approval Date Jul 7, 2015 N/A
Manufacturer Mylan Pharmaceuticals Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A